Case Report: ALK rearranged locally advanced lung adenocarcinoma showing inconsistent radiographic findings and pathological responses during neoadjuvant alectinib therapy.

导出 LinkOut

翻译打印收藏纠错

作者： Peijun,Cao ^[1] ; Qingchun,Zhao ^[1] ; Yongwen,Li ^[2] ; Ruifeng,Shi ^[1] ; Guangsheng,Zhu ^[1] ; Zihe,Zhang ^[1] ; Hongbing,Zhang ^[1] ; Minghui,Liu ^[1] ; Sen,Wei ^[1] ; Hongyu,Liu ^[2] ; Jun,Chen ^[1]

作者单位： Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China. ^[1] Tianjin Lung Cancer Institute, Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Medical University General Hospital, Tianjin, China. ^[2]

关键词 EML4-ALK fusion gene alectinib neoadjuvant therapy pseudoresistance pulmonary adenocarcinoma

DOI 10.3389/fphar.2023.1140894

PMID 37663243

发布时间 2023-09-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2023年14卷

1140894页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Case Report: ALK rearranged locally advanced lung adenocarcinoma showing inconsistent radiographic findings and pathological responses during neoadjuvant alectinib therapy.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Case Report: ALK rearranged locally advanced lung adenocarcinoma showing inconsistent radiographic findings and pathological responses during neoadjuvant alectinib therapy.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除